Review Article
Takotsubo Cardiomyopathy and Autoimmune Disorders: A Systematic Scoping Review of Published Cases
Table 5
Echocardiography findings in 155 patients with Takotsubo cardiomyopathy associated with autoimmune disease, n (%).
| | | Male (n = 25) | Female (n = 130) | Total (n = 155) |
| | First EF (EF1) | | Not reported | 12 (38%) | 29 (22.3%) | 41 (26.5%) | | Reported | 13 (52%) | 101 (77.7%) | 114 (73.5%) | | Reduced EF1 | 13 (52%) | 100 (76.9%) | 113 (72.9%) | | Normal EF1 | 0 (0%) | 1 (0.8%) | 1 (0.6%) | | Mean EF1 (%) | 28.1 ± 10.7 | 29.8 ± 9 | 29.6 ± 9.2 | | Recovery EF (EF2) | | Not reported | 11 (44.0%) | 34 (26.2%) | 45 (29%) | | Reported EF2 | 14 (56.0%) | 96 (73.8%) | 110 (71%) | | Reduced EF2 | 0 (0%) | 7 (5.4%) | 7 (4.5%) | | Normal EF2 | 14 (56.0%) | 89 (68.5%) | 103 (66.5%) | | Mean EF2 ± SD (%) | 63.2 ± 6.6 | 58.3 ± 9 | 58.9 ± 8.8 | | EF recovery time | | Not applicable | 9 (5.7%) | 26 (20%) | 35 (22.6%) | | Reported | 16 (10.1%) | 104 (80%) | 120 (77.4%) | | Recovery time in days, median (IQR) | 36.00 (14.00–82.50) | 18.50 (8.50–42.00) | 18.50 (10.00–42) |
|
|
EF: ejection fraction.
|
